CRIXIVAN 400 mg (Crixivan 400 mg)
Generic Name: indinavir
Pill imprint CRIXIVAN 400 mg has been identified as Crixivan 400 mg.
Crixivan is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Crixivan 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- indinavir
- Imprint:
- CRIXIVAN 400 mg
- Strength:
- 400 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0573
- Inactive Ingredients:
- lactose anhydrous
magnesium stearate
gelatin
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 52959-0507 | H.J. Harkins Company, Inc (repackager) |
| 54569-8620 | A-S Medication Solutions, LLC (repackager) |
| 16590-0064 | Stat RX USA LLC (repackager) |
| 35356-0139 | Lake Erie Medical and Surgical Supply (repackager) |
| 21695-0366 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
More about Crixivan (indinavir)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
